Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study.

Tiehuis AM, van der Graaf Y, Mali WP, Vincken K, Muller M, Geerlings MI; SMART Study Group.

Diabetes Care. 2014 Sep;37(9):2515-21. doi: 10.2337/dc14-0154. Epub 2014 Jun 19.

PMID:
24947788
2.

Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Portet F, Brickman AM, Stern Y, Scarmeas N, Muraskin J, Provenzano FA, Berr C, Bonafé A, Artero S, Ritchie K, Akbaraly TN.

Alzheimers Dement. 2012 Oct;8(5 Suppl):S88-95.e1. doi: 10.1016/j.jalz.2011.11.007. Epub 2012 Jun 6.

3.

Arterial stiffness and progression of structural brain changes: The SMART-MR study.

Jochemsen HM, Muller M, Bots ML, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2015 Feb 3;84(5):448-55. doi: 10.1212/WNL.0000000000001201. Epub 2014 Dec 31.

PMID:
25552578
4.

Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.

van der Veen PH, Muller M, Vincken KL, Hendrikse J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Stroke. 2015 May;46(5):1233-8. doi: 10.1161/STROKEAHA.114.008030. Epub 2015 Mar 24.

5.

Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.

Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, van der Graaf Y; SMART Study Group.

Atherosclerosis. 2010 May;210(1):130-6. doi: 10.1016/j.atherosclerosis.2009.10.039. Epub 2009 Nov 10.

PMID:
19945704
6.

Low cerebral blood flow is associated with lower memory function in metabolic syndrome.

Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, Gallagher CL, Koscik RL, Jonaitis EM, Hermann BP, LaRue A, Rowley HA, Asthana S, Sager MA, Bendlin BB.

Obesity (Silver Spring). 2013 Jul;21(7):1313-20. doi: 10.1002/oby.20170. Epub 2013 May 19.

7.

Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2012 Nov 13;79(20):2029-36. doi: 10.1212/WNL.0b013e3182749f02. Epub 2012 Oct 31.

PMID:
23115210
8.

Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.

Park JH, Kwon HM.

Clin Neurol Neurosurg. 2008 Mar;110(3):215-21. Epub 2007 Dec 4.

PMID:
18055103
9.

Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.

Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D.

Am Heart J. 2007 Apr;153(4):552-8.

PMID:
17383293
10.

Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.

Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F.

Diabetes Res Clin Pract. 2010 Mar;87(3):342-7. doi: 10.1016/j.diabres.2009.11.010. Epub 2009 Dec 8.

PMID:
20004035
11.

Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.

Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A.

J Atheroscler Thromb. 2007 Apr;14(2):78-85.

12.

Early vascular lesions in subjects with metabolic syndrome and prediabetes.

Diamantopoulos EJ, Andreadis EA, Tsourous GI, Katsanou PM, Georgiopoulos DX, Nestora KC, Raptis SA.

Int Angiol. 2006 Jun;25(2):179-83.

13.

Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Yao M, Jouvent E, During M, Godin O, Hervé D, Guichard JP, Zhu YC, Gschwendtner A, Opherk C, Dichgans M, Chabriat H.

Stroke. 2012 Dec;43(12):3252-7. doi: 10.1161/STROKEAHA.112.664854.

14.

Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study.

Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, van der Graaf Y, Geerlings MI; SMART Study Group.

Stroke. 2011 Nov;42(11):3105-9. doi: 10.1161/STROKEAHA.110.594853. Epub 2011 Aug 25.

15.

The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.

Bello-Rodriguez BM, Sanchez-Cruz G, Delgado-Bustillo F, Asiama G.

Ghana Med J. 2013 Dec;47(4):189-96.

16.
17.

Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans.

Choi HS, Cho YM, Kang JH, Shin CS, Park KS, Lee HK.

Clin Endocrinol (Oxf). 2009 Aug;71(2):184-8. doi: 10.1111/j.1365-2265.2008.03444.x. Epub 2008 Oct 13.

PMID:
19178513
18.

Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.

Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, Kappelle LJ, Mali WP; SMART Study Group.

Stroke. 2008 May;39(5):1600-3. doi: 10.1161/STROKEAHA.107.506089. Epub 2008 Mar 27.

19.

Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: the SMART-MR study.

van der Veen PH, Muller M, Vincken KL, Witkamp TD, Mali WP, van der Graaf Y, Geerlings MI; SMART-MR Study Group.

J Neurol Sci. 2014 Feb 15;337(1-2):112-8. doi: 10.1016/j.jns.2013.11.029. Epub 2013 Nov 27.

20.

Metabolic syndrome relates to lacunar stroke without white matter lesions: a study in first-ever lacunar stroke patients.

Zhang CE, van Raak EP, Rouhl RP, Lodder J, Staals J, Knottnerus IL, van Oostenbrugge RJ.

Cerebrovasc Dis. 2010;29(5):503-7. doi: 10.1159/000297967. Epub 2010 Mar 19.

PMID:
20299791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk